Archivos suplementarios
Palabras clave
Neurología
Pediatría
SARS-CoV-2
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Realizar una revisión integradora encaminada a esclarecer la prevalencia de casos de encefalitis por Covid-19 en la edad pediátrica, estableciendo los puntos en común que permitan dilucidar la relación de estas dos patologías. Métodos: Se evaluaron un total de 375 artículos, a través de los criterios de inclusión y exclusión, quedando un total de 8 artículos detallados en forma de tabla. Resultados: Se identificó predominio masculino (62,5%) y mayor incidencia entre los 10 y 18 años. La mayoría de los casos se manejaron inicialmente como encefalitis, con pruebas posteriores y confirmación viral en el LCR. Demostrando que los síntomas neurológicos pueden representar los primeros síntomas de la infección por SARS-CoV-2, y deben tenerse en cuenta durante las evaluaciones clínicas. Consideraciones finales: Aunque el aislamiento viral en líquido cefalorraquídeo es poco frecuente, la investigación de COVID en pacientes pediátricos con afecciones neurológicas es de suma importancia. Con el objetivo de un diagnóstico precoz y un mejor manejo clínico del caso a corto y largo plazo y que permita un resultado clínico positivo.
Referencias
AHMAD I, RATHORE FA. Neurological manifestations and complications of covid-19: a literature review. Journal of Clinical Neuroscience, 2020; 77: 8-12.
AHMED MU, et al. Neurological manifestations of Covid-19 (Sars-cov-2): A review. Frontiers in Neurology, 2020; 11: 518.
AGHAGOLI G, et al. Neurological involvement in covid-19 and potential mechanisms: a review. Neurocritical Care Journal, 2020; 34(3): 1062-1071.
ALEXOPOULOS H, et al. Anti-Sars- Cov-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients. Neurology Neuroimmunology & Neuroinflammation, 2020; 7: 6.
BUNYAVANICH S, et al. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. Journal of The American Medical Association, 2020; 323: 24-27.
CHEN TH. Neurological involvement associated with covid-19 infection in children. Journal of Clinical Neuroscience, 2020; 418: 117-96.
CHERAGHALI F, et al. Case report: detection of Sars-Cov-2 from cerebrospinal fluid in a 34-month-old child with encephalitis. Frontiers in Pediatrics, 2021; 9: 56-78.
COSTA BK, SATO DK. Viral encephalitis: a practical review on diagnostic approach and treatment. Journal de Pediatria, 2020; 96(s1): 9-12.
ELLUL MA, et al. Neurological associations of Covid-19. The Lancet neurology, 2020; 19(9): 767-83.
QUN L, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The Lancet respiratory, 2020; 382 (13): 1199-1207.
FERDOSIAN F, et al. Encephalitis associated with covid-19 in a 7-year-old boy: a case report. Case reports in clinical practice, 2021; 6(6): 246-250.
FERREIRA AC, CORREA-RODAS M. Acute meningoencephalitis as initial presentation of sars-cov-2 infection in pediatrics. The Pediatric Infectious Disease Journal, 2020; 39(11): 386-387.
GOMES I, et al. Sars-cov-2 infection of the central nervous system in a 14-month-old child: a case report of a complete autopsy. The Lancet Regional Health – Americas, 2021; 2: 1000-46.
GREGORY AD, et al. Regulation of systemic and local neutrophil responses by G-CSF during pulmonary pseudomonas aeruginosa infection. Blood Journal, 2007; 109: 3235–3243.
GUAN WJ, et al. China medical treatment expert group for covid-19. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine, 2020; 382: 1708-1720.
HAIDER H, et al. Covid-19 and the brain: acute encephalitis as a clinical manifestation. Cureus Journal of Medical Science 2020; 12: 107-84.
HEINONEN S, et al. Nasal Expression of Sars-Cov-2 entry receptors in newborns. Archives. Of Disease in Childhood - Fetal and Neonatal Edition, 2022; 107(1): 95-97.
HUO L, et al. Clinical features of sars-cov-2-associated encephalitis and meningitis amid covid-19 pandemic. World Journal of Clinical Cases, 2021; 9(5): 1058-1078.
KAMAL YM, et al. Cerebrospinal fluid confirmed covid-19-associated encephalitis treated successfully. The British Medical Journal – Case Report, 2020; 13(9): 237-378.
LI YC, et al. The neuroinvasive potential of Sars-Cov2 may be at least partially responsible for the respiratory failure of Covid-19 patients. Journal of Medical Virology, 2020; 92(6): 552-55.
MCABEE GN, et al. Encephalitis associated with covid-19 infection in an 11-year-old child. Journal of Pediatric Neurology, 2020; 109: 94.
MEHTA P, et al. Covid-19: Consider cytokine storm syndromes and immunosuppression. The Lancet, 2020; 395: 1033-4.
MIRANDA HENRIQUES-SOUZA AM, et al. Acute disseminated encephalomyelitis in a Covid-19 pediatric patient. Neuroradiology Journal, 2021; 63(1): 141–5.
MIRZAEE S, et al. Focal cerebral arteriopathy in a pediatric patient with covid-19. Journal of Radiology, 2020; 297(2): 274–5.
MIZUGUCHI M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain and Development Journal, 1997; 19: 81–92.
NUZZO D, PICONE P. Potential neurological effects of severe covid-19 infection. Journal of Neuroscience Research, 2020; 158: 1–5.
O’LOUGHLIN L, et al. A systematic review of severe neurological manifestations in pediatric patients with coexisting Sars-cov-2 infection. Surgical Neurology International, 2021; 13: 410–427.
PANDEY M. Acute meningoencephalitis in a child secondary to Sars-Cov-2 virus. Indian Pediatrics, 2021; 58(2): 183-184.
SÁNCHEZ-MORALES AE, et al. Neurological manifestations temporally associated with sars-cov-2 infection in pediatric patients in Mexico. Childs Nervous System – Journal, 2021; 37(7): 2305-2312.
SINGER TG, et al. Coronavirus infections in the nervous system of children: a scoping review making the case for long-term neurodevelopmental surveillance. Journal of Pediatric Neurology, 2021; 117: 47–63.
SINGH A, et al. Secretion of the chemokine interleukin-8 during Japanese encephalitis virus infection. Journal of Medical Microbiology, 2000; 49: 607–612.
SIRACUSA L, et al. Neurological complications in pediatric patients with Sars-Cov-2 infection: a systematic review of the literature. Italian Journal of Pediatrics, 2021; 47(1): 123.
URSO L, et al. The case of encephalitis in a covid-19 pediatric patient. Neurological sciences. Journal of the Italian neurological society and of the Italian society of clinical neurophysiology, 2022; 43(1): 105–112.
VENKATESAN A, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clinical Infectious Diseases, 2013; 57: 11-14.
VOLLONO C, et al. Focal status epilepticus as unique clinical feature of covid-19: a case report. Seizure – European Journal of Epilepsy, 2020; 78: 109-112.
WANG D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Journal of The American Medical Association, 2020; 323: 1061–1069.
YOUSEFI K, et al. Viral meningitis associated with covid-19 in a 9-year-old child: a case report. The Pediatric infectious Disease Journal, 2021; 40(2): 87-98.
ZHOU Z, et al. Understanding the neurotropic characteristics of sars-cov-2: from neurological manifestations of covid-19 to potential neurotropic mechanisms. The Journal of Neurology, 2020; 267(8): 2179-84.
ZUBAIR AS, et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. Journal of The American Medical Association, 2020; 77(8): 1018-1027.